img

Global Thrombin (Human) Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Thrombin (Human) Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Thrombin (Human) report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Thrombin (Human) market is projected to reach US$ 704.7 million in 2034, increasing from US$ 565 million in 2022, with the CAGR of 3.2% during the period of 2024 to 2034. Demand from Biotechnology and Medicine are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Thrombin (Human) industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Thrombin (Human) key manufacturers include Baxter, AMRESCO Inc, BD Biosciences, Life Technologies Corporation, PromoCell GmbH, Sigma-Aldrich Corporation, Vitrolife AB, CSL and Bayer, etc. Baxter, AMRESCO Inc, BD Biosciences are top 3 players and held % sales share in total in 2022.
Thrombin (Human) can be divided into 500IU/Vial, 1000IU/Vial and 2500IU/Vial,, etc. 500IU/Vial is the mainstream product in the market, accounting for % sales share globally in 2022.
Thrombin (Human) is widely used in various fields, such as Biotechnology, Medicine, Microbiology and Others, etc. Biotechnology provides greatest supports to the Thrombin (Human) industry development. In 2022, global % sales of Thrombin (Human) went into Biotechnology filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Thrombin (Human) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Baxter
AMRESCO Inc
BD Biosciences
Life Technologies Corporation
PromoCell GmbH
Sigma-Aldrich Corporation
Vitrolife AB
CSL
Bayer
Grifols
Octapharma
Shanghai RAAS
Hualan Biological
Segment by Type
500IU/Vial
1000IU/Vial
2500IU/Vial

Segment by Application


Biotechnology
Medicine
Microbiology
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Thrombin (Human) market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Thrombin (Human), product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Thrombin (Human) industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Thrombin (Human) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Thrombin (Human) introduction, etc. Thrombin (Human) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Thrombin (Human) market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Thrombin (Human) Market Overview
1.1 Thrombin (Human) Product Overview
1.2 Thrombin (Human) Market Segment by Type
1.2.1 500IU/Vial
1.2.2 1000IU/Vial
1.2.3 2500IU/Vial
1.3 Global Thrombin (Human) Market Size by Type
1.3.1 Global Thrombin (Human) Market Size Overview by Type (2018-2034)
1.3.2 Global Thrombin (Human) Historic Market Size Review by Type (2018-2024)
1.3.3 Global Thrombin (Human) Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Thrombin (Human) Sales Breakdown by Type (2018-2024)
1.4.2 Europe Thrombin (Human) Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Thrombin (Human) Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Thrombin (Human) Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Thrombin (Human) Sales Breakdown by Type (2018-2024)
2 Global Thrombin (Human) Market Competition by Company
2.1 Global Top Players by Thrombin (Human) Sales (2018-2024)
2.2 Global Top Players by Thrombin (Human) Revenue (2018-2024)
2.3 Global Top Players by Thrombin (Human) Price (2018-2024)
2.4 Global Top Manufacturers Thrombin (Human) Manufacturing Base Distribution, Sales Area, Product Type
2.5 Thrombin (Human) Market Competitive Situation and Trends
2.5.1 Thrombin (Human) Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Thrombin (Human) Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Thrombin (Human) as of 2022)
2.7 Date of Key Manufacturers Enter into Thrombin (Human) Market
2.8 Key Manufacturers Thrombin (Human) Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Thrombin (Human) Status and Outlook by Region
3.1 Global Thrombin (Human) Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Thrombin (Human) Historic Market Size by Region
3.2.1 Global Thrombin (Human) Sales in Volume by Region (2018-2024)
3.2.2 Global Thrombin (Human) Sales in Value by Region (2018-2024)
3.2.3 Global Thrombin (Human) Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Thrombin (Human) Forecasted Market Size by Region
3.3.1 Global Thrombin (Human) Sales in Volume by Region (2024-2034)
3.3.2 Global Thrombin (Human) Sales in Value by Region (2024-2034)
3.3.3 Global Thrombin (Human) Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Thrombin (Human) by Application
4.1 Thrombin (Human) Market Segment by Application
4.1.1 Biotechnology
4.1.2 Medicine
4.1.3 Microbiology
4.1.4 Others
4.2 Global Thrombin (Human) Market Size by Application
4.2.1 Global Thrombin (Human) Market Size Overview by Application (2018-2034)
4.2.2 Global Thrombin (Human) Historic Market Size Review by Application (2018-2024)
4.2.3 Global Thrombin (Human) Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Thrombin (Human) Sales Breakdown by Application (2018-2024)
4.3.2 Europe Thrombin (Human) Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Thrombin (Human) Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Thrombin (Human) Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Thrombin (Human) Sales Breakdown by Application (2018-2024)
5 North America Thrombin (Human) by Country
5.1 North America Thrombin (Human) Historic Market Size by Country
5.1.1 North America Thrombin (Human) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Thrombin (Human) Sales in Volume by Country (2018-2024)
5.1.3 North America Thrombin (Human) Sales in Value by Country (2018-2024)
5.2 North America Thrombin (Human) Forecasted Market Size by Country
5.2.1 North America Thrombin (Human) Sales in Volume by Country (2024-2034)
5.2.2 North America Thrombin (Human) Sales in Value by Country (2024-2034)
6 Europe Thrombin (Human) by Country
6.1 Europe Thrombin (Human) Historic Market Size by Country
6.1.1 Europe Thrombin (Human) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Thrombin (Human) Sales in Volume by Country (2018-2024)
6.1.3 Europe Thrombin (Human) Sales in Value by Country (2018-2024)
6.2 Europe Thrombin (Human) Forecasted Market Size by Country
6.2.1 Europe Thrombin (Human) Sales in Volume by Country (2024-2034)
6.2.2 Europe Thrombin (Human) Sales in Value by Country (2024-2034)
7 Asia-Pacific Thrombin (Human) by Region
7.1 Asia-Pacific Thrombin (Human) Historic Market Size by Region
7.1.1 Asia-Pacific Thrombin (Human) Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Thrombin (Human) Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Thrombin (Human) Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Thrombin (Human) Forecasted Market Size by Region
7.2.1 Asia-Pacific Thrombin (Human) Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Thrombin (Human) Sales in Value by Region (2024-2034)
8 Latin America Thrombin (Human) by Country
8.1 Latin America Thrombin (Human) Historic Market Size by Country
8.1.1 Latin America Thrombin (Human) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Thrombin (Human) Sales in Volume by Country (2018-2024)
8.1.3 Latin America Thrombin (Human) Sales in Value by Country (2018-2024)
8.2 Latin America Thrombin (Human) Forecasted Market Size by Country
8.2.1 Latin America Thrombin (Human) Sales in Volume by Country (2024-2034)
8.2.2 Latin America Thrombin (Human) Sales in Value by Country (2024-2034)
9 Middle East and Africa Thrombin (Human) by Country
9.1 Middle East and Africa Thrombin (Human) Historic Market Size by Country
9.1.1 Middle East and Africa Thrombin (Human) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Thrombin (Human) Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Thrombin (Human) Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Thrombin (Human) Forecasted Market Size by Country
9.2.1 Middle East and Africa Thrombin (Human) Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Thrombin (Human) Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Baxter
10.1.1 Baxter Company Information
10.1.2 Baxter Introduction and Business Overview
10.1.3 Baxter Thrombin (Human) Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Baxter Thrombin (Human) Products Offered
10.1.5 Baxter Recent Development
10.2 AMRESCO Inc
10.2.1 AMRESCO Inc Company Information
10.2.2 AMRESCO Inc Introduction and Business Overview
10.2.3 AMRESCO Inc Thrombin (Human) Sales, Revenue and Gross Margin (2018-2024)
10.2.4 AMRESCO Inc Thrombin (Human) Products Offered
10.2.5 AMRESCO Inc Recent Development
10.3 BD Biosciences
10.3.1 BD Biosciences Company Information
10.3.2 BD Biosciences Introduction and Business Overview
10.3.3 BD Biosciences Thrombin (Human) Sales, Revenue and Gross Margin (2018-2024)
10.3.4 BD Biosciences Thrombin (Human) Products Offered
10.3.5 BD Biosciences Recent Development
10.4 Life Technologies Corporation
10.4.1 Life Technologies Corporation Company Information
10.4.2 Life Technologies Corporation Introduction and Business Overview
10.4.3 Life Technologies Corporation Thrombin (Human) Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Life Technologies Corporation Thrombin (Human) Products Offered
10.4.5 Life Technologies Corporation Recent Development
10.5 PromoCell GmbH
10.5.1 PromoCell GmbH Company Information
10.5.2 PromoCell GmbH Introduction and Business Overview
10.5.3 PromoCell GmbH Thrombin (Human) Sales, Revenue and Gross Margin (2018-2024)
10.5.4 PromoCell GmbH Thrombin (Human) Products Offered
10.5.5 PromoCell GmbH Recent Development
10.6 Sigma-Aldrich Corporation
10.6.1 Sigma-Aldrich Corporation Company Information
10.6.2 Sigma-Aldrich Corporation Introduction and Business Overview
10.6.3 Sigma-Aldrich Corporation Thrombin (Human) Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Sigma-Aldrich Corporation Thrombin (Human) Products Offered
10.6.5 Sigma-Aldrich Corporation Recent Development
10.7 Vitrolife AB
10.7.1 Vitrolife AB Company Information
10.7.2 Vitrolife AB Introduction and Business Overview
10.7.3 Vitrolife AB Thrombin (Human) Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Vitrolife AB Thrombin (Human) Products Offered
10.7.5 Vitrolife AB Recent Development
10.8 CSL
10.8.1 CSL Company Information
10.8.2 CSL Introduction and Business Overview
10.8.3 CSL Thrombin (Human) Sales, Revenue and Gross Margin (2018-2024)
10.8.4 CSL Thrombin (Human) Products Offered
10.8.5 CSL Recent Development
10.9 Bayer
10.9.1 Bayer Company Information
10.9.2 Bayer Introduction and Business Overview
10.9.3 Bayer Thrombin (Human) Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Bayer Thrombin (Human) Products Offered
10.9.5 Bayer Recent Development
10.10 Grifols
10.10.1 Grifols Company Information
10.10.2 Grifols Introduction and Business Overview
10.10.3 Grifols Thrombin (Human) Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Grifols Thrombin (Human) Products Offered
10.10.5 Grifols Recent Development
10.11 Octapharma
10.11.1 Octapharma Company Information
10.11.2 Octapharma Introduction and Business Overview
10.11.3 Octapharma Thrombin (Human) Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Octapharma Thrombin (Human) Products Offered
10.11.5 Octapharma Recent Development
10.12 Shanghai RAAS
10.12.1 Shanghai RAAS Company Information
10.12.2 Shanghai RAAS Introduction and Business Overview
10.12.3 Shanghai RAAS Thrombin (Human) Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Shanghai RAAS Thrombin (Human) Products Offered
10.12.5 Shanghai RAAS Recent Development
10.13 Hualan Biological
10.13.1 Hualan Biological Company Information
10.13.2 Hualan Biological Introduction and Business Overview
10.13.3 Hualan Biological Thrombin (Human) Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Hualan Biological Thrombin (Human) Products Offered
10.13.5 Hualan Biological Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Thrombin (Human) Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Thrombin (Human) Industrial Chain Analysis
11.4 Thrombin (Human) Market Dynamics
11.4.1 Thrombin (Human) Industry Trends
11.4.2 Thrombin (Human) Market Drivers
11.4.3 Thrombin (Human) Market Challenges
11.4.4 Thrombin (Human) Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Thrombin (Human) Distributors
12.3 Thrombin (Human) Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of 500IU/Vial
Table 2. Major Company of 1000IU/Vial
Table 3. Major Company of 2500IU/Vial
Table 4. Global Thrombin (Human) Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Thrombin (Human) Sales by Type (2018-2024) & (K Units)
Table 6. Global Thrombin (Human) Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Thrombin (Human) Sales by Type (2018-2024) & (US& Million)
Table 8. Global Thrombin (Human) Market Share in Value by Type (2018-2024)
Table 9. Global Thrombin (Human) Price by Type (2018-2024) & (USD/Unit)
Table 10. Global Thrombin (Human) Sales by Type (2024-2034) & (K Units)
Table 11. Global Thrombin (Human) Sales Market Share in Volume by Type (2024-2034)
Table 12. Global Thrombin (Human) Sales by Type (2024-2034) & (US$ Million)
Table 13. Global Thrombin (Human) Sales Market Share in Value by Type (2024-2034)
Table 14. Global Thrombin (Human) Price by Type (2024-2034) & (USD/Unit)
Table 15. North America Thrombin (Human) Sales by Type (2018-2024) & (K Units)
Table 16. North America Thrombin (Human) Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Thrombin (Human) Sales (K Units) by Type (2018-2024)
Table 18. Europe Thrombin (Human) Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Thrombin (Human) Sales (K Units) by Type (2018-2024)
Table 20. Asia-Pacific Thrombin (Human) Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Thrombin (Human) Sales (K Units) by Type (2018-2024)
Table 22. Latin America Thrombin (Human) Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Thrombin (Human) Sales (K Units) by Type (2018-2024)
Table 24. Middle East and Africa Thrombin (Human) Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Thrombin (Human) Sales by Company (2018-2024) & (K Units)
Table 26. Global Thrombin (Human) Sales Share by Company (2018-2024)
Table 27. Global Thrombin (Human) Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Thrombin (Human) Revenue Share by Company (2018-2024)
Table 29. Global Market Thrombin (Human) Price by Company (2018-2024) & (USD/Unit)
Table 30. Global Thrombin (Human) Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Thrombin (Human) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Thrombin (Human) as of 2022)
Table 33. Date of Key Manufacturers Enter into Thrombin (Human) Market
Table 34. Key Manufacturers Thrombin (Human) Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Thrombin (Human) Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 37. Global Thrombin (Human) Sales by Region (2018-2024) & (K Units)
Table 38. Global Thrombin (Human) Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Thrombin (Human) Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Thrombin (Human) Sales Market Share in Value by Region (2018-2024)
Table 41. Global Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 42. Global Thrombin (Human) Sales by Region (2024-2034) & (K Units)
Table 43. Global Thrombin (Human) Sales Market Share in Volume by Region (2024-2034)
Table 44. Global Thrombin (Human) Sales by Region (2024-2034) & (US$ Million)
Table 45. Global Thrombin (Human) Sales Market Share in Value by Region (2024-2034)
Table 46. Global Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 47. Global Thrombin (Human) Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 48. Global Thrombin (Human) Sales by Application (2018-2024) & (K Units)
Table 49. Global Thrombin (Human) Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Thrombin (Human) Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Thrombin (Human) Sales Market Share in Value by Application (2018-2024)
Table 52. Global Thrombin (Human) Price by Application (2018-2024) & (USD/Unit)
Table 53. Global Thrombin (Human) Sales by Application (2024-2034) & (K Units)
Table 54. Global Thrombin (Human) Sales Market Share in Volume by Application (2024-2034)
Table 55. Global Thrombin (Human) Sales by Application (2024-2034) & (US$ Million)
Table 56. Global Thrombin (Human) Sales Market Share in Value by Application (2024-2034)
Table 57. Global Thrombin (Human) Price by Application (2024-2034) & (USD/Unit)
Table 58. North America Thrombin (Human) Sales by Application (2018-2024) (K Units)
Table 59. North America Thrombin (Human) Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Thrombin (Human) Sales by Application (2018-2024) (K Units)
Table 61. Europe Thrombin (Human) Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Thrombin (Human) Sales by Application (2018-2024) (K Units)
Table 63. Asia-Pacific Thrombin (Human) Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Thrombin (Human) Sales by Application (2018-2024) (K Units)
Table 65. Latin America Thrombin (Human) Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Thrombin (Human) Sales by Application (2018-2024) (K Units)
Table 67. Middle East and Africa Thrombin (Human) Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Thrombin (Human) Sales by Country (2018-2024) & (K Units)
Table 69. North America Thrombin (Human) Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Thrombin (Human) Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Thrombin (Human) Sales Market Share in Value by Country (2018-2024)
Table 72. North America Thrombin (Human) Sales by Country (2024-2034) & (K Units)
Table 73. North America Thrombin (Human) Sales Market Share in Volume by Country (2024-2034)
Table 74. North America Thrombin (Human) Sales by Country (2024-2034) & (US$ Million)
Table 75. North America Thrombin (Human) Sales Market Share in Value by Country (2024-2034)
Table 76. Europe Thrombin (Human) Sales by Country (2018-2024) & (K Units)
Table 77. Europe Thrombin (Human) Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Thrombin (Human) Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Thrombin (Human) Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Thrombin (Human) Sales by Country (2024-2034) & (K Units)
Table 81. Europe Thrombin (Human) Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe Thrombin (Human) Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe Thrombin (Human) Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific Thrombin (Human) Sales by Region (2018-2024) & (K Units)
Table 85. Asia-Pacific Thrombin (Human) Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Thrombin (Human) Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Thrombin (Human) Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Thrombin (Human) Sales by Region (2024-2034) & (K Units)
Table 89. Asia-Pacific Thrombin (Human) Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific Thrombin (Human) Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Thrombin (Human) Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America Thrombin (Human) Sales by Country (2018-2024) & (K Units)
Table 93. Latin America Thrombin (Human) Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Thrombin (Human) Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Thrombin (Human) Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Thrombin (Human) Sales by Country (2024-2034) & (K Units)
Table 97. Latin America Thrombin (Human) Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America Thrombin (Human) Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America Thrombin (Human) Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa Thrombin (Human) Sales by Country (2018-2024) & (K Units)
Table 101. Middle East and Africa Thrombin (Human) Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Thrombin (Human) Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Thrombin (Human) Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Thrombin (Human) Sales by Country (2024-2034) & (K Units)
Table 105. Middle East and Africa Thrombin (Human) Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa Thrombin (Human) Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa Thrombin (Human) Sales Market Share in Value by Country (2024-2034)
Table 108. Baxter Company Information
Table 109. Baxter Introduction and Business Overview
Table 110. Baxter Thrombin (Human) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 111. Baxter Thrombin (Human) Product
Table 112. Baxter Recent Development
Table 113. AMRESCO Inc Company Information
Table 114. AMRESCO Inc Introduction and Business Overview
Table 115. AMRESCO Inc Thrombin (Human) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 116. AMRESCO Inc Thrombin (Human) Product
Table 117. AMRESCO Inc Recent Development
Table 118. BD Biosciences Company Information
Table 119. BD Biosciences Introduction and Business Overview
Table 120. BD Biosciences Thrombin (Human) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 121. BD Biosciences Thrombin (Human) Product
Table 122. BD Biosciences Recent Development
Table 123. Life Technologies Corporation Company Information
Table 124. Life Technologies Corporation Introduction and Business Overview
Table 125. Life Technologies Corporation Thrombin (Human) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 126. Life Technologies Corporation Thrombin (Human) Product
Table 127. Life Technologies Corporation Recent Development
Table 128. PromoCell GmbH Company Information
Table 129. PromoCell GmbH Introduction and Business Overview
Table 130. PromoCell GmbH Thrombin (Human) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 131. PromoCell GmbH Thrombin (Human) Product
Table 132. PromoCell GmbH Recent Development
Table 133. Sigma-Aldrich Corporation Company Information
Table 134. Sigma-Aldrich Corporation Introduction and Business Overview
Table 135. Sigma-Aldrich Corporation Thrombin (Human) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 136. Sigma-Aldrich Corporation Thrombin (Human) Product
Table 137. Sigma-Aldrich Corporation Recent Development
Table 138. Vitrolife AB Company Information
Table 139. Vitrolife AB Introduction and Business Overview
Table 140. Vitrolife AB Thrombin (Human) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 141. Vitrolife AB Thrombin (Human) Product
Table 142. Vitrolife AB Recent Development
Table 143. CSL Company Information
Table 144. CSL Introduction and Business Overview
Table 145. CSL Thrombin (Human) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 146. CSL Thrombin (Human) Product
Table 147. CSL Recent Development
Table 148. Bayer Company Information
Table 149. Bayer Introduction and Business Overview
Table 150. Bayer Thrombin (Human) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 151. Bayer Thrombin (Human) Product
Table 152. Bayer Recent Development
Table 153. Grifols Company Information
Table 154. Grifols Introduction and Business Overview
Table 155. Grifols Thrombin (Human) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 156. Grifols Thrombin (Human) Product
Table 157. Grifols Recent Development
Table 158. Octapharma Company Information
Table 159. Octapharma Introduction and Business Overview
Table 160. Octapharma Thrombin (Human) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 161. Octapharma Thrombin (Human) Product
Table 162. Octapharma Recent Development
Table 163. Shanghai RAAS Company Information
Table 164. Shanghai RAAS Introduction and Business Overview
Table 165. Shanghai RAAS Thrombin (Human) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 166. Shanghai RAAS Thrombin (Human) Product
Table 167. Shanghai RAAS Recent Development
Table 168. Hualan Biological Company Information
Table 169. Hualan Biological Introduction and Business Overview
Table 170. Hualan Biological Thrombin (Human) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 171. Hualan Biological Thrombin (Human) Product
Table 172. Hualan Biological Recent Development
Table 173. Key Raw Materials Lists
Table 174. Raw Materials Key Suppliers Lists
Table 175. Thrombin (Human) Market Trends
Table 176. Thrombin (Human) Market Drivers
Table 177. Thrombin (Human) Market Challenges
Table 178. Thrombin (Human) Market Restraints
Table 179. Thrombin (Human) Distributors List
Table 180. Thrombin (Human) Downstream Customers
Table 181. Research Programs/Design for This Report
Table 182. Key Data Information from Secondary Sources
Table 183. Key Data Information from Primary Sources
List of Figures
Figure 1. Thrombin (Human) Product Picture
Figure 2. Global Thrombin (Human) Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Thrombin (Human) Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Thrombin (Human) Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of 500IU/Vial
Figure 6. Global 500IU/Vial Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of 1000IU/Vial
Figure 8. Global 1000IU/Vial Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of 2500IU/Vial
Figure 10. Global 2500IU/Vial Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Global Thrombin (Human) Sales by Type (2018-2034) & (US$ Million)
Figure 12. Global Thrombin (Human) Sales Market Share by Type in 2022 & 2034
Figure 13. North America Thrombin (Human) Sales Market Share in Volume by Type in 2022
Figure 14. North America Thrombin (Human) Sales Market Share in Value by Type in 2022
Figure 15. Europe Thrombin (Human) Sales Market Share in Volume by Type in 2022
Figure 16. Europe Thrombin (Human) Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Thrombin (Human) Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Thrombin (Human) Sales Market Share in Value by Type in 2022
Figure 19. Latin America Thrombin (Human) Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Thrombin (Human) Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Thrombin (Human) Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Thrombin (Human) Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Thrombin (Human) Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Thrombin (Human) Revenue in 2022
Figure 25. Thrombin (Human) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Biotechnology
Figure 27. Global Biotechnology Sales YoY Growth (2018-2034) & (K Units)
Figure 28. Product Picture of Medicine
Figure 29. Global Medicine Sales YoY Growth (2018-2034) & (K Units)
Figure 30. Product Picture of Microbiology
Figure 31. Global Microbiology Sales YoY Growth (2018-2034) & (K Units)
Figure 32. Product Picture of Others
Figure 33. Global Others Sales YoY Growth (2018-2034) & (K Units)
Figure 34. Global Thrombin (Human) Sales by Application (2018-2034) & (US$ Million)
Figure 35. Global Thrombin (Human) Sales Market Share by Application in 2022 & 2034
Figure 36. North America Thrombin (Human) Sales Market Share in Volume by Application in 2022
Figure 37. North America Thrombin (Human) Sales Market Share in Value by Application in 2022
Figure 38. Europe Thrombin (Human) Sales Market Share in Volume by Application in 2022
Figure 39. Europe Thrombin (Human) Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Thrombin (Human) Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Thrombin (Human) Sales Market Share in Value by Application in 2022
Figure 42. Latin America Thrombin (Human) Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Thrombin (Human) Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Thrombin (Human) Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Thrombin (Human) Manufacturing Cost Structure
Figure 47. Thrombin (Human) Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed